For the prevention and management of uterine hemorrhage1
Methergine® is the Only FDA-Approved Oral Uterotonic1,2
For the prevention and management of uterine hemorrhage1
Methergine® is the Only
FDA-Approved Oral Uterotonic1,2
Postpartum Hemorrhage (PPH) is a leading
cause of maternal morbidity and mortality3

Uterine atony is a primary cause of PPH, and accounts for what percentage of cases?

Help the Knowledge Exchange
in the fight against
maternal morbidity and mortality

image

Severe maternal morbidity affects over 60,000 women each year4

Every 10 minutes a woman in the US nearly dies of pregnancy-related complications4

Severe maternal morbidity affects over 60,000 women each year4

Every 10 minutes a woman in the US nearly dies of pregnancy-related complications4

PPH is on the Rise3...

Did you know that most cases can be anticipated if you know the risks?

Ensure your patients are
protected from Hospital to Home

Lupin Pharmaceuticals, Inc. has been dedicated to women's health for nearly a decade with a range of products developed for women's health and well-being.

References
  1. Methergine® (methylergonovine maleate) 0.2 mg Tablets Prescribing Information.
  2. U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.
    Available at: http://www.accessdata.fda.gov/scripts/cder/ob/docs/tempai.cfm. Accessed March 4, 2016.
  3. Bateman BT, Tsen LC, Liu J, et al. Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011. Anesth Analg. 2014;119:1344-1349.
  4. Creanga AA, Berg CJ, Ko JY, et al. Maternal mortality and morbidity in the United States: Where are we now? J Women’s Health. 2014;23(1): 3-9.